Citations for
1ADAM23
Endocytosis of the non-catalytic ADAM23: Recycling and long half-life properties.
Souza ILM, Oliveira NH, Huamaní PAM, Martin AS, Borgonovo ZLM, Nakao LS, Zanata SM.
Exp Cell Res. Jan 15;398(2):112415. doi: 10.1016/j.yexcr.2020.112415. Epub 2020 Dec 6 2021
2ADAM22, ADAM23, LGI1
ADAM22 and ADAM23 modulate the targeting of the Kv1 channel-associated protein LGI1 to the axon initial segment
Hivert B, Marien L, Agbam KN, Faivre-Sarrailh C.
J Cell Sci. Jan 16;132(2):jcs219774. doi: 10.1242/jcs.219774. 2019
3ADAM23
ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK - AKT Signaling.
Xiang M, Luo H, Wu J, Ren L, Ding X, Wu C, Chen J, Chen S, Zhang H, Yu L, Zou Y, Xu H, Ye P, Chen M, Xia J.
J Am Heart Assoc. Sep 18;7(18):e008604. doi: 10.1161/JAHA.118.008604. 2018
4ADAM22, ADAM23, LGI3
Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma.
Kwon NS, Kim DS, Yun HY.
Onco Targets Ther. May 24;10:2721-2728. doi: 10.2147/OTT.S138912. 2017
5ADAM23
ADAM23 promotes neuronal differentiation of human neural progenitor cells
Markus-Koch A, Schmitt O, Seemann S, Lukas J, Koczan D, Ernst M, Fuellen G, Wree A, Rolfs A, Luo J.
Cell Mol Biol Lett. Aug 18;22:16. doi: 10.1186/s11658-017-0045-1. 2017
6ADAM22, ADAM23, EPT, LGI1
Secretion-Positive LGI1 Mutations Linked to Lateral Temporal Epilepsy Impair Binding to ADAM22 and ADAM23 Receptors.
Dazzo E, Leonardi E, Belluzzi E, Malacrida S, Vitiello L, Greggio E, Tosatto SC, Nobile C.
PLoS Genet 12(10):e1006376. doi: 10.1371/journal.pgen.1006376. eCollection 2016 Oct. 2016
7ADAM23
ADAM23 knockdown promotes neuronal differentiation of P19 embryonal carcinoma cells by up-regulating P27KIP1 expression
Wang Y, Sun Y, Qiao S.
Cell Biol Int. ;36(12):1275-9. doi: 10.1042/CBI20120154. 2012
8ADAM23, LGI3
Leucine-rich glioma inactivated 3 regulates adipogenesis through ADAM23
Kim HA, Park WJ, Jeong HS, Lee HE, Lee SH, Kwon NS, Baek KJ, Kim DS, Yun HY.
Biochim Biophys Acta. Jun;1821(6):914-22. doi: 10.1016/j.bbalip.20 2012
9ADAM23
SP1 acts as a key factor, contributes to upregulation of ADAM23 expression under serum deprivation.
Pan Q, Yang S, Wei Y, Sun F, Li Z.
Biochem Biophys Res Commun 401(2):306-12. Epub 2010 Sep 17.PMID: 20851106 2010
10ADAM10, ADAM17, ADAM22, ADAM23, ADAM9
Regional expression of the ADAMs in developing chicken cochlea.
Yan X, Lin J, Wang H, Markus A, Wree A, Rolfs A, Luo J.
Dev Dyn 239(8):2256-65.PMID: 20658692 2010
11ADAM10, ADAM17, ADAM22, ADAM23, ADAM9
Expression of seven members of the ADAM family in developing chicken spinal cord.
Lin J, Yan X, Markus A, Redies C, Rolfs A, Luo J.
Dev Dyn 239(4):1246-54.PMID: 20235233 2010
12ADAM23, LGI1
LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology.
Owuor K, Harel NY, Englot DJ, Hisama F, Blumenfeld H, Strittmatter SM.
Mol Cell Neurosci 42(4):448-57. Epub 2009 Sep 29.PMID: 19796686 2009
13ADAM23, PRNP
Characterization of a specific interaction between ADAM23 and cellular prion protein.
Costa MD, Paludo KS, Klassen G, Lopes MH, Mercadante AF, Martins VR, Camargo AA, Nakao LS, Zanata SM.
Neurosci Lett 461(1):16-20. Epub 2009 May 27.PMID: 19477226 2009
14ADAM23
ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasis.
Verbisck NV, Costa ET, Costa FF, Cavalher FP, Costa MD, Muras A, Paixão VA, Moura R, Granato MF, Ierardi DF, Machado T, Melo F, Ribeiro KB, Cunha IW, Lima VC, Maciel Mdo S, Carvalho AL, Soares FF, Zanata S, Sogayar MC, Chammas R, Camargo AA.
Cancer Res 69(13):5546-52. Epub 2009 Jun 23.PMID: 19549921 2009
15ADAM23
Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues.
Choi JS, Kim KH, Jeon YK, Kim SH, Jang SG, Ku JL, Park JG.
Int J Cancer 124(6):1258-62.PMID: 19089928 2009
16ADAM11, ADAM22, ADAM23, LGI1, LGI4
LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11.
Sagane K, Ishihama Y, Sugimoto H.
Int J Biol Sci 4(6):387-96. Epub 2008 Oct 21.PMID: 18974846 2008
17ADAM23
ADAM23 plays multiple roles in neuronal differentiation of P19 embryonal carcinoma cells.
Sun Y, Wang Y, Zhang J, Tao J, Wang C, Jing N, Wu C, Deng K, Qiao S.
Neurochem Res 32(7):1217-23. Epub 2007 Feb 9.PMID: 17333391 2007
18ADAM23
ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
Takada H, Imoto I, Tsuda H, Nakanishi Y, Ichikura T, Mochizuki H, Mitsufuji S, Hosoda F, Hirohashi S, Ohki M, Inazawa J.
Oncogene 24(54):8051-60. 2005
19ADAM23
Two novel isoforms of Adam23 expressed in the developmental process of mouse and human brains.
Sun YP, Deng KJ, Wang F, Zhang J, Huang X, Qiao S, Zhao S.
Gene 325:171-8. 2004
20ADAM23
ADAM23 is a cell-surface glycoprotein expressed by central nervous system neurons.
Goldsmith AP, Gossage SJ, ffrench-Constant C.
J Neurosci Res 78(5):647-58. 2004
21ADAM23
ADAM 23/MDC3, a human disintegrin that promotes cell adhesion via interaction with the alphavbeta3 integrin through an RGD-independent mechanism.
Cal S, Freije JM, Lopez JM, Takada Y, Lopez-Otin C.
Mol Biol Cell 11(4):1457-69. 2000
22ADAM21, ADAM22, ADAM23
The identification of seven metalloproteinase-disintegrin (ADAM) genes from genomic libraries.
Poindexter K, Nelson N, DuBose RF, Black RA, Cerretti DP.
Gene 237(1):61-70 1999
23ADAM22, ADAM23
Metalloproteinase-like, disintegrin-like, cysteine-rich proteins MDC2 and MDC3: novel human cellular disintegrins highly expressed in the brain.
Sagane K, Ohya Y, Hasegawa Y, Tanaka I.
Biochem J 334 ( Pt 1):93-8 1998